Selonsertib (gs-4997) is a selective ASK1 inhibitor that reduces metabolic parameters, inflammation, and fibrosis in multi-drug resistance and non-alcoholic hepatitis [64, 65]. This evidence concerns the gene MAP3K5 and alcoholic hepatitis.